TALLC Corporation

TALLC Corporation is a preclinical-stage ophthalmology company developing novel mechanism-of-action drugs for corneal surgery, chronic retinal conditions, and chronic diseases. TALLC Corporation aims to become a leading provider in the ophthalmology pipeline, achieving better clinical and commercial outcomes.